Bellevue Semaglutide Injection Eligibility Test For 30+ BMI: Weight Loss Update

Dr. Otoño Silva of Interventional Orthopedics of Washington now offers an eligibility assessment for FDA-approved injectable semaglutide for weight loss. Semaglutide GLP-1 agonists are available at a third of the cost of popular brand-name medications.

Bellevue, United States - October 11, 2023 /PressCable/ —

Interventional Orthopedics of Washington has expanded its medical weight loss options, now offering semaglutide treatments for effective and affordable weight management. Patients in Bellevue, WA, now have access to affordable alternatives to Wegovy and Ozempic. Due to high demand, these brand-name semaglutide injections are often expensive or unavailable in local pharmacies.

More details can be found at https://www.bellevueweightloss.info

The newly offered semaglutide treatment provides patients struggling with obesity with a proven medical solution for healthy, long-term weight loss. The appetite-suppressing drug is available at the clinic for a fraction of the cost of brand-name versions, which are often out of stock.

Semaglutide was initially approved as a treatment for type 2 diabetes but has become increasingly used off-label for weight loss after research showed it is highly effective. A 2021 study published in The New England Journal of Medicine found that obese and overweight patients taking a 2.4 mg daily dose of semaglutide lost an average of 14.9% body weight over 68 weeks. This was compared to just 2.4% average weight loss in the placebo group over the same period.

Dr. Otoño Silva provides patients cost-effective access to weekly semaglutide injections after an initial assessment at his Bellevue clinic. The customized treatment pricing is based on the required starting and maintenance doses but is available at almost a third of the cost of brand-name semaglutide drugs. His assessment considers a patient's body mass index (BMI), general health, weight-associated health conditions, general level of fitness, and other important markers that determine whether they qualify for weekly semaglutide injections.

As an appetite suppressant, semaglutide helps patients lose weight by mimicking GLP-1, a hunger-suppressing hormone, allowing them to eat less without struggling with cravings or an unsatisfied appetite. This treatment makes it easier to lose weight through dietary changes and increased activity than risky weight-loss options such as gastric bypass, gastric banding, and stomach stapling.

Along with aiding weight loss, semaglutide provides additional health benefits like improved blood sugar control, reduced diabetes risk, lower cholesterol, and potential neuroprotective effects. These changes can reduce the risk of obesity-related cardiovascular disease and other chronic illnesses.

"I'm kind of shocked by my results," said a satisfied patient. "I'm not hungry, and I don't even think about food very much, but I keep losing weight."

More information on semaglutide treatment for weight loss and other services offered by Dr. Silva at Interventional Orthopedics of Washington can be found at https://www.bellevueweightloss.info

Contact Info:
Name: Otoño Silva, MD
Email: Send Email
Organization: Interventional Orthopedics of Washington
Address: 1515 116th Ave NE Suite 202, Bellevue, WA 98004, United States
Phone: +1-425-326-1665
Website: https://iowmed.com

Source: PressCable

Release ID: 89109997

In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com. Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.